Dirction:Tyr-Somatostatin-14 (GT-P1731, CAS 58100-03-1) is a synthetic peptide with a disulfide bridge between Cys4 and Cys15. Its formula is C₈₅H₁₁₃N₁₉O₂₁S₂ and MW 1801.09. Manufactured via solid-phase peptide synthesis, it is supplied for endocrine and somatostatin receptor related academic research with reliable purity.

eolas bunúsach:
branda: síneadh soladach
tréithe cuma:bánpúdar
stóráil: scáthú, fionnuartriomú,íonacht caomhnaithe séalaithe: ≥ 99% príomhúsáid: Úsáid Taighde Polypeptide
forghníomhúcaighdeán: caighdeán fiontair
sonraíochtaí:mg/g/kg, srl (faoi réir riachtanais an chustaiméara)
díolacháin Raon feidhme: Domhanda
ceisteanna coitianta peptide:
1. How to judge whether the quality of peptide synthesis is qualified?
Each polypeptide will come: -HPLC chromatogram (purity test) -MS (Molecular Weight Verification) after the customer receives it, it can be verified again in combination with the experimental requirements, and can be retested and confirmed if necessary.
2. Cad iad na modhnuithe a dtacaítear leo? An gcuireann an modhnú isteach ar an timthriall?
Supporting modifications include, but are not limited: -Fluorescent labeling (FITC, Cy5, etc.) -Cyclization, phosphorylation, fatty acid -Biotinylation, C- terminal amidation, N-terminal acetylation, etc. Complex modification will appropriately extend the synthesis cycle, generally 7 to 12 working days, it is recommended to evaluate in advance.